Skip to main content

Advertisement

Table 1 Baseline characteristics of study participants

From: Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial

Variable 3-Day Routine Change Group (n = 177) Clinically Indicated Change Group (n = 185)
Sex - Male, n (%) 96 (54%) 103 (56%)
Age, mean (SD) 65.1 (17.3) 62.7 (15.4)
Reason for admission, n (%)   
   • Gastrointestinal 46 (26%) 52 (28%)
   • Respiratory 37 (21%) 34 (18%)
   • Oncology 21 (12%) 21 (11%)
   • Orthopaedic 16 (9%) 22 (12%)
   • Cardiac 10 (6%) 10 (5%)
   • Neurological 9 (5%) 10 (5%)
   • Vascular 7 (4%) 7 (4%)
   • Renal 16 (9%) 9 (5%)
   • Other 15 (8%) 20 (11%)
Number of comorbidities, n (%)   
   • None 6 (3.4%) 10 (5.4%)
   • 1 22 (12.4%) 21 (11.4%)
   • 2 44 (24.9%) 54 (29.2%)
   • >2 105 (59.3%) 100 (54.1%)
Type of surgery, n (%)   
   • Nil 124 (70%) 132 (71%)
   • Gastrointestinal 22 (12%) 22 (12%)
   • Orthopaedic 8 (5%) 15 (8%)
   • Other 23 (13%) 16 (9%)
Most recent Hb - Mean (SD) 124.8 (23.2) 126.2 (21.9)